Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 4

The DOI matches its Crossref record.

Einfluss von Medikamenten auf urologische Krankheiten

Thürmann, P. A.·2016·Der Urologe
DOI 10.1007/s00120-016-0040-6
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00120-016-0040-6

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 31

  1. Knopf H, Grams G (2013) Arzneimittelanwendung von Erwachsenen in Deutschland. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsbl 56:868–877 · DOI
  2. Thürmann PA (2014) Polypharmazie. Treiben Sie den Teufel nicht mit dem Beelzebub aus! MMW Fortschr Med 156(10):56–61 · DOI
  3. Krüger-Brand HE (2015) Arzneimitteltherapie: Medikationsplan für mehr Sicherheit. Dtsch Arztebl 112(35-36):A-1410–A-1414
  4. Wefer B, Loch A (2014) Harninkontinenz im Erwachsenenalter. In: Schmelz H‑U, Sparwasser C, Weidner W (Hrsg) Facharztwissen Urologie. Springer, Berlin, S 467–485 · DOI
  5. Gust K, Bartsch G, Haferkamp A (2014) Funktionsstörungen des unteren Harntraktes. In: Hautmann R, Gschwend JE (Hrsg) Urologie. Springer, Berlin, S 111–130
  6. Tsakiris P, Oelke M, Michel MC (2008) Drug-induced urinary incontinence. Drugs Aging 25(7):541–549 · DOI
  7. Schneider T, Rübben H, Michel MC (2003) Die medikamenten-induzierte Dysfunktion der Harnblase. Urologe 42:1588–1593 · DOI
  8. Drake MJ, Nicon PM, Crew JP (1998) Drug-induced bladder and urinary disorders. Drug Saf 19(1):45–55 · DOI
  9. Movig KLL, Leufkens HGM, Belitser SV, Lenderink AW, Egberts ACG (2002) Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol Drug Saf 11:271–279 · DOI
  10. Basu M, Duckett JRA (2009) Update on duloxetine for the management of stress urinary incontinence. Clin Interv Aging 4:25–30
  11. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE et al (2013) The women’s health initiative hormone therapy trials: update and overview of health outcomes during the intervention and post-stopping phases. JAMA 310(13):1353–1368 · DOI · Paper page
  12. Moehrer B, Hextall A, Jackson S (2003) Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2003(2):CD001405
  13. Cody JD, Richardson K, Moehrer B, Hextall A, Glazener CM (2009) Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 4:CD001405
  14. Verhamme KMC, Sturkenboom MCJM, Stricker BHC, Bosch R (2008) Drug-induced urinary retention. Drug Saf 31(5):373–388 · DOI · Paper page
  15. Kaplan SA, Roehrborn CG, Rovner ES et al (2006) Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA 296(19):2319–2328 · DOI
  16. Knoll T (2014) Urolithiasis. In: Schmelz HU, Sparwasser C, Weidner W (Hrsg) Facharztwissen Urologie. Springer, Berlin, S 122–136
  17. Pfau A, Eckardt KU, Knauf F (2015) Diagnostik und Therapie der Nephrolithiasis. Internist 1–6. doi:10.1007/s00108-015-3758-0 · DOI
  18. Daudon M, Jungers P (2004) Drug-induced renal calculi. Drugs 64(3):245–275 · DOI
  19. Izzedine H, Lescure FX, Bonnet F (2014) HIV medication-based urolithiasis. Clin Kidney J 7:121–126 · DOI
  20. Regensburger M, Huttner HB, Doerfler A, Schwab S, Staykov D (2014) Propofol-related urine discoloration in a patient with fatal atypical intracerebral hemorrhage treated with hypothermia. Springerplus 3:551 · DOI
  21. Stadler Th, Bader M, Ückert S, Staehler M, Becker A, Stief CG (2006) Adverse effects of drug therapies on male and female sexual function. World J Urol 24:623–629 · DOI
  22. Baldwin TS, Foong T (2013) Antidepressant drugs and sexual dysfunction. Br J Psychiatr 202:396–397 · DOI
  23. Fava M, Nurnberg HG, Seidman SN, Holloway W, Nicholas S, Tseng LJ, Stecher VJ (2006) Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 67:240–246 · DOI
  24. Park YW, Kim Y, Lee JH (2012) Antipsychotic-induced sexual dysfunction and its management. World J Mens Health 30:153–159 · DOI
  25. Schmidt HM, Hagen M, Kriston L, Soares-Weiser K, Maayan N, Berner MM (2012) Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev 11:CD003546
  26. Bauer J, Klingmüller D (2008) Welches Antiepileptikum für den Mann? Kritische Beurteilung aktueller Kenntnisse aus epileptologischer und andrologischer Sicht. Nervenarzt 79:1407–1415 · DOI
  27. Nicolai MPJ, Liem SS, Both S, Pelger RCM, Putter H, Schalij MJ, Elzevier HW (2013) What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I. Neth Heart J 21:540–544 · DOI
  28. Dusing R (2005) Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. Drugs 65(6):773–786 · DOI
  29. Dusing R (2003) Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press Suppl 2003(2):29–34 · DOI
  30. Fogari R, Preti P, Zoppi A et al (2004) Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens 17(1):77–81 · DOI
  31. Andersohn F, Schmedt N, Weinmann S, Willich SN, Garbe E (2010) Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. J Clin Psychopharmacol 30:68–71 · DOI

Cited by

Metadata

Authors
Thürmann, P. A.
Venue
Der Urologe
Publisher
Springer Science and Business Media LLC
Published
2016-02-23
Volume
55
Issue
3
Pages
401-411
ISSN
  • 0340-2592
  • 1433-0563
DOI
10.1007/s00120-016-0040-6
Cited by
4
References
0
Language
de
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.